Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

r 3, VALSTAR(TM) became commercially available for the treatment of a distinct form of bladder cancer. VALSTAR represents a new treatment option for patients who may otherwise have exhausted all other FDA-approved treatment alternatives.

On September 24, Endo announced the final results of a cash tender offer by one of its wholly owned subsidiaries, for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes. This offer resulted in Endo's acquiring $48 million of the $105 million aggregate principal amount that was outstanding and reflects the company's ongoing efforts to manage its capital structure.

Selected Product Review

PAIN PRODUCTS

LIDODERM®: For the quarter ended September 30, 2009, net sales of LIDODERM were $193 million comparable to $194 million in the same period a year ago. For the nine months ended September 30, 2009, net sales of LIDODERM were flat at $560 million compared with $560 million in the same period a year ago.

OPANA® ER and OPANA®: Combined net sales for the OPANA franchise increased 42 percent to $59 million for the third quarter 2009 compared with $41 million in the same period a year ago. For the nine months ended September 30, 2009, combined net sales for the OPANA franchise increased 30 percent to $167 million compared with $128 million in the same period a year ago.

FROVA®: Net sales of FROVA were $15 million for the three months ended September 30, 2009 compared with $14 million for the same period in 2008. Net sales of FROVA were $42 million for the nine months ended September 30, 2009 compared with $41 million for the same period in 2008.

Voltaren® Gel: Net sales of Voltaren Gel were $20 million for the three months ended September 30, 2009 compared with $10 million for the same period in 2008. Net sales of Voltaren Gel were $57 million for the nine months ended Sep
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... "Copay coupons," a drug manufacturer ... drugs among patients with prescription drug coverage, may now be ... report  from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to ... the federal government. The report ...
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... -- Kiromic, LLC, a Lubbock bio-pharmaceutical ... the former chancellor of Texas Tech University, to its board ... 2014, after raising $1.2 billion for the university. ... the most successful chancellor in the history of Texas Tech ... investor, but also as our new vice chairman of the ...
Breaking Medicine Technology:PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
... 23, 2011 Starpharma Holdings Limited (ASX: SPL, OTCQX: ... 2 clinical study that demonstrated efficacy of VivaGel(R) for ... Key Points: VivaGel(R) meets primary ... VivaGel(R) expected to avoid many shortcomings of existing therapies ...
... in Guilford is one of six Maine companies recently honored ... employees, and to manufacturing or service excellence, with the 21st ... by the Maine Department of Economic and Community Development, the ... 17 at the State House in the Hall of Flags. ...
Cached Medicine Technology:VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 2VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 3VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 4VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 5Hardwood Products Wins Formal Acclaim From Gov. LePage for Excellence and Community Commitment 2Hardwood Products Wins Formal Acclaim From Gov. LePage for Excellence and Community Commitment 3
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... filings continue to grow in federal court, Bernstein ... Food & Drug Administration (FDA) have voted overwhelmingly ... low testosterone in men be subjected to further ... According to a report published on September 18th ...
(Date:9/20/2014)... 19, 2014 (HealthDay News) -- The avian flu that ... could be spread through respiratory drops and therefore poses ... study. Although no human illnesses have been linked ... Children,s Research hospital have discovered natural mutations to the ... travel through the air in droplets. Current seasonal ...
(Date:9/20/2014)... September 20, 2014 Ticket Down ... concert tickets for her 2015 “Honeymoon Tour.” This well-known ... for added savings. , In early 2015, fans will have ... the world across North America. Twenty-one-year-old Ariana Grande will hit ... will take her to 25 cities across the United States ...
(Date:9/20/2014)... September 20, 2014 iFitDress.com, the popular ... for women, has recently unveiled its new collection of ... sale for special offer on these new outfits; it ... season. All customers can now buy cheap cocktail ... company’s sales representative says, “We have extensive experience in ...
(Date:9/20/2014)... have advised their patients against drinking coffee and wine. Dr. ... advice and changing his stance after considering two recent studies ... health. “There’s good news and great news,” says Dr. Wells, ... against gum disease, and red wine can help fight cavities!” ... September 2014 issue of Boston University School of Medicine ...
Breaking Medicine News(10 mins):Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3
... HealthDay Reporter , TUESDAY, March 6 (HealthDay News) -- ... have significantly less asthma and allergies than Swiss children who ... What,s more, the Amish youngsters even have less ... up on non-Amish farms. The study could support ...
... TUESDAY, March 6 (HealthDay News) -- A smoking ban ... underweight babies, a new study finds. The nationwide ban ... The researchers analyzed data on preterm delivery and small-for-gestational-age babies ... of mothers who smoked dropped from more than 25 percent ...
... , TUESDAY, March 6 (HealthDay News) -- Vitamin D deficiency ... with an increased risk of death, a new study finds. ... vitamin D deficiency, according to lead author Dr. Stefan Pilz, ... Their study of nearly 1,000 female nursing home residents, ...
... patients in the United States remain in care consistently, according ... the University of Pennsylvania published online this week in ... is the first to provide a comprehensive national estimate of ... most likely to continue their treatment over time. "Helping ...
... March 6, 2012 Dr. Eric Olson ... UT Southwestern Medical Center, has won the 2012 Passano ... development of the heart and other muscles. In ... that Dr. Olson,s discoveries at the interface of developmental ...
... York, NY (March 5, 2012) Today, the ... Accelerating Cancer Cures Research Symposium, focused on rebuilding ... laboratory discoveries into new cancer therapies. The event, ... scientists and other leading pharmaceutical companies, including Eli ...
Cached Medicine News:Health News:Amish Farm Kids Have Lower Asthma, Allergy Risk: Study 2Health News:Amish Farm Kids Have Lower Asthma, Allergy Risk: Study 3Health News:Amish Farm Kids Have Lower Asthma, Allergy Risk: Study 4Health News:Lack of Vitamin D May Harm Older Women's Health 2Health News:1 in 4 US HIV patients don't stay in care, Penn study shows 2Health News:1 in 4 US HIV patients don't stay in care, Penn study shows 3Health News:Olson, noted UT Southwestern molecular biologist, wins 2012 Passano Award 2Health News:Olson, noted UT Southwestern molecular biologist, wins 2012 Passano Award 3Health News:Industry leaders join together for historic Accelerating Cancer Cures Research Symposium 2
... an option beyond traditional methods for ... low back pain. The new Orthotrac,Pneumatic ... chronic back pain. In fact, associated ... of application.,The Orthotrac is the only ...
Optical Urethrotome for Telescope 1.9 mm for neonates and children....
Optical Urethrotome for Telescope 2.7 mm for children....
Optical Mini Urethrotome for telescope 3.3 mm, 0...
Medicine Products: